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Introduction: Patients with bilateral adrenal damage due to heparin-induced thrombocytopenia usually need life-
long steroid substitution. So far, no data exists about the natural evolution of such a condition, especially about ad-
renal function recovery and the real need for lifelong steroids.
Case presentation: An 81-year-old Caucasian woman with bilateral adrenal damage due to heparin-induced
thrombocytopenia presented with fever and severe hypotension. Adrenal failure was confirmed biologically and
radiologically. She eventually recovered her adrenal function, allowing for steroid withdrawal.
Conclusions: This case report addresses the different mechanisms of adrenal damage due to heparin-induced
thrombocytopenia and its natural evolution with potential recovery. This should encourage clinicians to evaluate
the real necessity for lifelong corticosteroid substitution in such a condition.
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Bilateral adrenal damage (BAD) due to heparin-induced
thrombocytopenia (HIT) is increasingly described in the
medical literature. It is a devastating condition leading
to adrenal insufficiency that needs rapid recognition and
subsequent steroid substitution. The main clinical mani-
festation is hemodynamic collapse. One of the most fre-
quently described mechanisms of adrenal damage is
thrombosis of the adrenal veins leading to hemorrhagic
necrosis of the glands. In case of adrenal insufficiency,
lifelong steroid substitution is generally proposed. How-
ever, the natural evolution of such a condition is not well
documented [1].
We present the case of a woman with HIT-associated
BAD, whose adrenal function recovered, allowing for
successful steroids tapering after three months. No re-
currence of adrenal insufficiency was observed during
two years of follow-up. This case clearly illustrates that
recovery of adrenal failure due to HIT-associated BAD is
possible. This should incite clinicians to regularly assess* Correspondence: jaafar.jaafar@hcuge.ch; mathieu.nendaz@hcuge.ch
1Department of Internal Medicine, Geneva University Hospitals and Faculty of
Medicine, Gabrielle-Perret-Gentil 4, Geneva 1211, Switzerland
Full list of author information is available at the end of the article
© 2015 Jaafar et al.; licensee BioMed Central. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.adrenal function through basal cortisol dosage and/or an
adrenocorticotropic hormone (ACTH) stimulation test.
Our report also illustrates different possible mechanisms
of adrenal injuries.
Case presentation
An 81-year-old Caucasian woman with a history of
anticoagulated atrial fibrillation (AF), had a sudden car-
diac arrest during a hospital visit, requiring 10 minutes
of cardiopulmonary resuscitation (CPR) performed im-
mediately after the arrest, allowing the restoration of
atrial fibrillation rhythm. She remained intubated for
three days. A coronary angiogram showed no significant
coronary disease, with a left ventricular ejection fraction
of 35%. Pulmonary embolism was ruled out by a com-
puted tomography (CT) scan on day 3, which showed
no other anomalies. There was neither electrolyte dis-
turbance nor drugs that could favor such an event. Cor-
onary spasm or idiopathic ventricular fibrillation was
finally retained as the cause for her cardiac arrest and an
internal defibrillator was implanted. Due to her past AF
history (CHADS score = 3), our patient received intra-
venous anticoagulation with unfractionated heparin
(UFH) upon arrival at the intensive care unit (ICU).his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tachycardia. Broad-spectrum antibiotics and inotropic
support with dobutamine and noradrenaline were
started.
Her platelet count dropped from 656 G/L on admis-
sion (our patient was known for an essential thrombocy-
tosis Jak-2 positive status) to 131G/L on day 10 and
129G/L on day 11 (Figure 1). Her 4T’s score was 8 and
positive anti-PF4-heparin antibodies were confirmed by
enzyme-linked immunosorbent assay (ELISA) (day 12).
UFH was stopped and therapeutic doses of fondaparinux
were immediately started. A thoraco-abdominal CT-
scan performed on day 14 showed multiple pulmonary
embolisms, splenic infarction and bilateral adrenal ische-
mia with subsequent hemorrhagic transformation on a
CT scan done later on day 21 for non-specific abdominal
pain (Figure 2). Diagnosis of HIT with thrombotic com-
plication was retained (HITT) and fondaparinux was
switched to lepirudin, at the same time her platelet
count was increasing (Figure 1). A Doppler ultrasound
(US) scan showed a distal deep venous thrombosis
(DVT) of the left peroneal vein (day 17). Her procalcito-
nin level was lower than 0.5μg/L from day 7 to day 15,
with high fibrinogen, which reasonably excluded the
diagnosis of sepsis with disseminated intravascular co-
agulation (DIC). Antiphospholipid syndrome was inves-
tigated; anticardiolipin immunoglobulin G (IgG) was
slightly positive in this elderly patient, whereas anticar-
diolipin IgM, anti beta2-glycoprotein antibody IgM and
IgG were all negative. Since the thrombotic events hap-
pened during heparin therapy and the platelet count in-
creased after heparin cessation, the diagnosis of HITT
was maintained.
Basal cortisol on day 15 was 63nmol/L (normal value
greater than 500nmol/L) and increased to 136nmol/L 60Figure 1 Platelet count (G/L) during the first 20 days of hospitalizatiominutes after injection of 250μg ACTH (considered nor-
mal if the cortisol value exceeds 500nmol/L). The diag-
nosis of adrenal insufficiency due to bilateral adrenal
damage in the context of HITT was made and our pa-
tient was given intravenous hydrocortisone 50mg three
times a day for five days and then received a mainten-
ance oral dose of 20mg in the morning and 10mg in the
afternoon, allowing for a quick hemodynamic improve-
ment. Inotropes and antibiotics were therefore stopped.
Following ICU discharge, she was weaned off hydrocor-
tisone progressively over the following weeks (Figure 3),
with close blood pressure surveillance, along with
plasmatic assessment of potassium and sodium levels
twice weekly. After one month of hospitalization, our
patient was discharged on 10mg hydrocortisone once daily
after a normal ACTH stimulation test. Substitution was
tapered further until a complete stop on day 45. Fifteen
days after cessation of hydrocortisone (day 60, Figure 3),
another ACTH stimulation test without oral substitution
showed complete normalization. (Basal cortisol was
224nmol/L and increased to 568nmol/L one hour post-
injection of 250μg of tetracosactide.) Two years later, the
ACTH test remained normal and showed a basal cortisol
at 138nmol/L that increased to 1540nmol/L one hour
post-injection of 250μg of tetracosatide (day 600, Figure 3).
The patient died of another cause three years after the
essential event.
Discussion
Up to 3 to 5% of patients exposed to UFH for at least
five days and 1% of those exposed to low-molecular-
weight heparin (LMWH) develop HIT during or after
treatment. A subset of these individuals also experience
arterial and/or venous thrombosis [2]. About 50% of pa-
tients presenting with isolated thrombocytopenian and its relation to heparin use.
Figure 2 Abdominal computed tomography scans. (A)
Abdominal computed tomography scan on day 3 showing normal
adrenal glands. (B) Abdominal computed tomography scan on day
14 showing infiltration with increased adrenal gland volume. (C)
Abdominal computed tomography scan on day 21 showing bilateral
adrenal hemorrhagic infarction. (D) Abdominal computed
tomography scan on day 435 showing small atrophic adrenal
glands.
Figure 3 Hydrocortisone doses and blood cortisol levels before
and after adrenocorticotropic hormone tests, over 600 days.
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them experience venous thrombosis with DVT and pul-
monary embolism (PE) identified as the most common ad-
verse events [3]. Other unusual complications of HIT
include adrenal hemorrhage as described in our case [4].
Predictive scores, such as the 4-T score [5], or the HEP
score [6], are helpful to assess the likelihood of HIT. Anti-
PF4 antibodies disappear in most patients after 90 to 120
days [7]. Treatment consists of discontinuation of heparin
and therapeutic anticoagulation with nonheparin anti-
thrombotic agents such as lepirudin and argatroban.
LMWH should not be used because of cross-reactivity
with HIT antibodies [2]. The safety and efficacy of fonda-
parinux have not been formally studied in patients withHIT and there is some divergence in its recommendation
in this setting [8].
Each adrenal gland is supplied by three suprarenal arter-
ies that originate from the inferior phrenic artery, the renal
artery, and the aorta. Their branches feed into a subcapsu-
lar plexus located in the adrenal cortex. This highly vascular
plexus drains into medullary sinusoids via relatively few
venous channels at the corticomedullary junction, thereby
creating a potential ‘vascular dam’ [9,10]. Additionally, the
adrenal glands are each drained by a single central vein
composed of thick longitudinal muscle bundles that create
further resistance to blood flow. Any increase in adrenal
venous pressure or arterial perfusion pressure may result in
hemorrhage into the gland. In cases of hypotension and de-
creased arterial perfusion, capillaries at the corticomedul-
lary junction are at risk of ischemic necrosis. When normal
arterial perfusion is restored, hemorrhage can also occur
due to reperfusion injury [10,11].
High concentrations of catecholamines are present in the
adrenal vein during times of stress. This may lead to ad-
renal vein constriction and increased venous pressure,
which can progress to hemorrhage, as described above.
Additionally, there is some evidence to suggest that the ad-
renal vein is prone to development of platelet thrombi in
areas of turbulence and local stasis due to catecholamine
release [10,11]. Thrombosis of the adrenal vein has been
thought to cause outflow obstruction, leading to adrenal
hemorrhage [10,11].
Heparin provokes adrenal hemorrhage in two ways. First,
heparin as an anticoagulant can potentiate bleeding risk
when administered during acute illness, thereby leading to
adrenal hemorrhage [10]. Second, in the setting of HIT,
thrombosis of the central adrenal vein can lead to subse-
quent adrenal hemorrhage [10]. In a study by Kovacs et al.
[11], patients exposed to heparin for four to six days and
over six days were approximately 17 and 34 times
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renal hemorrhage than those with no heparin exposure. Pa-
tients who developed thrombocytopenia were found to
have a 15 times greater risk for hemorrhage.
The presenting signs and symptoms of adrenal failure
generally include hypotension or shock, abdominal or flank
pain, fever, anorexia, nausea or vomiting, neuropsychiatric
symptoms such as confusion or disorientation, and abdom-
inal guarding or rebound tenderness [9]. Laboratory evalu-
ation may be normal or may show a significant alteration of
electrolyte levels and a drop in hemoglobin [10]. Tradition-
ally, adrenal insufficiency is diagnosed biochemically by
demonstrating low morning cortisol, which is independent
from ACTH deficiency and low mineralocorticoid secretion
in patients without ACTH deficiency. A short ACTH
stimulation test should be performed, unless the diagnosis
has been ruled out by a normal basal serum cortisol value
[9]. Chronic partial secondary adrenal insufficiency may not
be detected by the 250μg ACTH stimulation test. Its use is
controversial in critically ill patients, nevertheless there is
no other reliable test to assess the adrenocortical axis in this
setting [12]. In our case, the adrenal insufficiency diagnosis
was highly probable, given the clinical course, the biological
tests performed, and the sequence of CT images, although
the workup should ideally have included ACTH, renin and
aldosterone levels. Adrenal hemorrhage on CT scan is char-
acterized by a round or oval mass in the adrenal gland [13].
When acute adrenal insufficiency is confirmed, imme-
diate treatment involves fluid, electrolyte, and hydrocor-
tisone replacement. Mineralocorticoid replacement can
be added as needed once the dose of hydrocortisone is
less than 50mg daily [14]. Fludrocortisone, a potent syn-
thetic mineralocorticoid, is given orally at a usual dose
of 0.1mg/day. Patients with adrenal insufficiency after bi-
lateral adrenal hemorrhage are usually treated with long-
term oral steroids after hospital discharge, with the hy-
pothesis that irreversible adrenal damage has occurred
and probably because of lack of sufficient data about its
long-term evolution [9,15]. This raises the question of
identifying patients with potential chance of recovery
after adrenal damage due to HIT.
To our knowledge, this is the first reported clinical
situation demonstrating that some patients can recover
their adrenal function within a short period of time after
adrenal offense by HIT, allowing for discontinuation of
glucocorticoids [16,17]. For a corticosteroid-weaning
trial, one should be able to better characterize the mech-
anism of adrenal insufficiency and to identify subsets of
adrenal damage, including hemorrhagic damage, with
partial tissue necrosis. This would ideally be realized by
imaging modalities that could show the percentage of re-
sidual viable healthy tissue, which could finally indicate
the chance of weaning corticosteroids. Until such tests
are available to clinicians, our description suggests that acase-by-case evaluation and trial to withdraw steroids
under strict medical control may be attempted in ad-
renal damage due to HIT.
Conclusions
BAD in the context of HIT is a rare condition that needs
urgent recognition, withdrawal of heparin, and immedi-
ate substitution treatment with corticosteroids and non-
heparin antithrombotic therapy.
Patients usually receive lifelong steroid replacement
since the natural evolution of adrenal insufficiency in
this context is not known. Our case description suggests
that in the context of HIT, the damage mechanism
might increase the chance of adrenal recovery, thus
allowing for steroid withdrawal during follow-up. A
whole gland necrosis might not always be present, espe-
cially when venous thrombosis with adrenal congestion
is the cause of the deficiency. The next question will be
how to identify these patients and which withdrawal
protocol would be the most safe and effective.
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